Regulation: Commercial medications are FDA-approved, while compounded medications are not
Potential for improved adherence Patients taking transdermal patches have exhibited better adherence compared to other administration routes
Initial in vivo testing with GEP12 (5 and 10 mg/kg/day) resulted in robust reductions in food intake and body weight, albeit somewhat less than responses observed in rats treated with equivalent doses of GEP44 (Figs
After completion, as monitored by UPLC and ESI-LCMS, the reaction mixture was diluted with buffer A, filtered and purified directly by preparative RP-HPLC, eluting with a linear gradient (see the Peptide cleavage and purification section)
Clinical studies have shown that patients can expect significant weight loss (around 5-10% of their body weight) after about 6 months of consistent use, although individual results may vary based on lifestyle factors such as diet and exercise
Patients in Ro's program can get prescribed a GLP-1, and the company also offers compounded versions of the medication when the branded versions are in short supply
